Placement of external spinal neurostimulator generator A patient with chronic low back pain presents for placement of a Stimwave stimulator electrode into the epidural space. Consequently, measuring LBP outcomes in these patients is conservative and may mark the minimal expected improvement with this 3D neural targeting for LBP. Members functional disability assessed using the Oswestry Disability Index (ODI); member has received an ODI score greater than or equal to 21%. 2009;12(2):379-397. Eldabe et al (2015) reported on outcomes of DRG in phantom limb pain (PLP). Genom att klicka p Godknn alla godknner du att Yahoo och vra partner behandlar din personliga information och anvnder tekniker som cookies fr att visa personliga annonser och innehll, mta annonser och innehll, f information om mlgruppen och utveckla produkter. Interestingly, in 1 case, sleep efficiency improved even though pain intensity remained unchanged. An RCT testing 10-kHz SCS versus CMM in 216 participants with PDN revealed 76 % mean pain relief after 6 months of stimulation. } (2022) reported on additional secondary endpoints related to health-related quality of life (HRQoL). The stimulation devices used in PENS and PNT are not implanted, so CPT code 64590 is also not appropriate. None of the non-revascularization-based treatments were associated with a significant effect on mortality. The use of high-dose cervical spinal cord stimulation in the treatment of chronic upper extremity and neck pain. - Operant Billing. 2014;17(8):753-758; discussion 758. The literature supporting pre-surgical psychological clearance for DCS has been reviewed by a number of authors (Heckler et al, 2007; van Dorsten, 2006). Injury. The investigators stated that no unanticipated adverse events were reported and the safety profile was similar to other spinal cord stimulation studies. The clinical value of cervical SCS for these indications needs to be investigated by well-designed RCTs. Overall QOL was reported as improved/greatly improved by 73.1 % of patients at 3 months. Surg Neurol. 2021;49(1):1-22. De La Porte C, Van de Kelft E. Spinal cord stimulation in failed back syndrome. Clin Cardiol. Medtronic previously reported 3-month data from the trial in January 2020. Lastly, complications occurred in a total of 33 of the 213 patients, with a 1.6 % lead replacement rate and a 1.6 % explant rate. North RB, Kidd DH, Olin J, et al. This observation was supported by the findings of Anderson et al (1994) as well as Eliasson et al (1994). Carter ML. Stimwave's Tiny StimQ Wireless Peripheral Nerve Stimulator Cleared by FDA. Four before-and-after case-series studies (a total of 92 participants) met inclusion criteria. The lack of randomization plus need for insurance approval could also introduce selection bias for the patients who receive treatment and may not be representative of the broader population. At follow-up (mean of 14.4 months), pain was rated at 43.5mm. 1994;23(7):1592-1597. de Jongste MJL, Staal MJ. The mean VAS score before implantation (8.7) compared to VAS 12 months after implantation (4.0) was significantly lower (95 % CI: 3.9 to 5.4], p < 0.001). This includes (not an all-inclusive list)management of pain associated with chronic pancreatitis, treatment of persons in a chronic vegetative or minimally conscious state, abdominal pain related to celiac artery compression syndrome, chest wall/sternal pain, chronic abdominal pain, chronic limb ischemia, chronic malignant pain, chronic pelvic pain, chronic visceral pain, coccydynia, gait disorders including spinocerebellar ataxia, gastroparesis, Guillain Barre syndrome, irritable bowel syndrome, meralgia paresthetica, neurodegenerative ataxia, neuropathic pain associated with multiple sclerosis, Parkinson's disease, peri-rectal pain, sleep disorders, Sphincter of Odi dysfunction, types of chronic non-malignant non-neuropathic pain not mentioned above, and ventricular fibrillation and ventricular tachycardia. Korean J Pain. Cerebello-spinal tDCS showed a significant improvement in all performance scores (Scale for the Assessment and Rating of Ataxia, International Cooperative Ataxia Rating Scale, 9-Hole Peg Test, 8-meter walking time), in motor cortex excitability, and in cerebellar brain inhibition compared to sham stimulation. 45. In the CMM group, 95 completed 6-month follow-up and 81 % (77 of 95) crossed-over to 10-kHz SCS compared with 0 from the 10-kHz SCS + CMM arm (p < 0.001); 64 subjects received permanent device implants following cross-over. Ultimately, a SCS was implanted after a successful temporary percutaneous trial. In previous works, these researchers have described that cervical SCS can modify tumor microenvironment in HGG by increasing tumor blood flow, oxygenation, and metabolism. At 6-month follow-up, 187 patients were evaluated. } 1988;51(6):333-337. Intensive glycemic control with insulin in patients with type 1 DM may be associated with lower odds of distal symmetric polyneuropathy compared to patients who receive conventional insulin therapy. First, the retrospective nature of this study limited the systematic collection of patient data, including clinical characteristics, medication use, implantation details and QOL measures. The SCS device also had limitations placed on the programming of the device so that the comparison between the devices was not confounded by unique SCS device programming features. CPT codes for percutaneous implantation of neurostimulator electrodes (i.e., 64553-64561) are not appropriate since PENS and PNT use percutaneously inserted needles and wires rather than percutaneously implanted electrodes. Each subject was implanted with 2 epidural leads spanning C2 to C6 vertebral bodies. The data contained herein suggested SCS for C-FBSS was an effective therapy that improves QOL and patient satisfaction, as well as decreasing pain and PDI. They included 6 in-vitro and 8 in-vivo animal studies. Electrical storm ceased thereafter, though ventricular function from progressive cardiomyopathy worsened, requiring heart transplantation several months later. In contrast, HRP or LRP yielded weak or very weak correlations for these transcriptomes. Hope and Gruber (2012) noted that only 1 case report was found that discussed SCS for treatment of coccygodynia after a coccygeal fracture . the studys inclusion and exclusion criteria were purposefully left almost entirely open, with the exception of age and on-label treatment, in order to best mirror real world clinical practice. Lam CM, Monroe BR. The neurostimulators were trialed; 8 were successful and permanently implanted and programed to achieve optimal pain-paresthesia overlap. Complete data were available for 33 patients: the proportion of patients responding under HF-SCS was 42.4 % (14/33 patients) versus 30.3 % (10/33 patients) in the sham group. Spinal cord stimulation for patients with failed back surgery syndrome or complex regional pain syndrome: A systematic review of effectiveness and complications. The study was registered in the Collaborative Approach to Meta-Analysis and Review of Animal Data from Experimental Studies data base. Klicka p Hantera instllningar fr mer information och fr att hantera dina val. stimwave cpt code. Russo M, Van Buyten JP. Simpson et al (2009) examined the clinical and cost-effectiveness of SCS in the management of chronic neuropathic or ischemic pain. 2003;(3):CD004001. Midha M, Schmitt JK. Providers are to use CPT Code 64999 for both the trial and permanent insertion of the electrode array when billing for the procedures associated with either Peripheral Subcutaneous Field Stimulation or Peripheral Nerve Field Stimulation. FBSS after lumbar spine surgery and CRPS) for at least 6 months despite trying conventional approaches to pain management. While the exact pathophysiology is unknown, the pain states resultant from conditions such as interstitial cystitis and the like yield patients with a presentation that bears a striking similarity to neuropathic syndromes that are known to respond to neuromodulation. The authors concluded that while the basic science is encouraging, the therapeutic effectiveness of ESCS remains inconclusive. The overall motor score of the Unified Parkinson's Disease Rating Scale in the on/off-stimulation condition remained unchanged in 6 patients and improved in 18 patients after SCS. 2013;2:CD009389. Middleton P, Simpson B, Maddern G. Spinal cord stimulation (neurostimulation): An accelerated systematic review. While pain improved in only 5 out of 6 patients after SCS, sleep efficiency improved in all cases. The SCS system was implanted only if trial stimulation was successful. Acta Neurotic. 2022;45(1):e3-e6. 1996;21(11):1344-1351. Contrary to SCS, DRG stimulation (DRGS) delivers targeted target to focal areas, does not rely on paresthesias, and is able to reliably capture body parts like the pelvis making it an ideal modality for the treatment of CPP. There was a special subgroup of 5 patients with regular change of frequencies between high frequency and conventional frequency (with paresthesia) also with significant leg and LBP relief. 2014;17(4):E537-E541. Nonsurgical interventional therapies for low back pain: A review of the evidence for an American Pain Society clinical practice guideline. Thus, DRG stimulation at these levels may be effective for LBP by recruiting both segmental and non-segmental neural pathways that are not otherwise accessible via traditional SCS. The pre-specified primary endpoint was percentage of participants with 50 % pain relief or more on VAS without worsening of baseline neurological deficits at 3 months. At 24 months post-implant, pain intensity decreased significantly from baseline (NRS=4.2, n=169, p<0.0001) and even more in in the severe pain subgroup (NRS=5.3, n=91, p<0.0001). Trial of a cervical SCS system using a basic tonic waveform produced positive outcomes in hand tremor, head-nodding and daily functioning. A total of 373 MS patients were submitted to a stimulation trial, and 82 MS patients underwent a de-novo implantation; 285/373 (76.4 %) of cases submitted to the SCS trial were enrolled for permanent stimulation. Information om din enhet och internetanslutning, som din IP-adress, Din skaktivitet nr du anvnder Yahoos webbplatser och appar. 61868 . The authors concluded that in 3 patients, HD cervical spinal cord stimulation successfully controlled upper extremity chronic pain/paresthesias. Identified studies on such targeted intra-spinal stimulation were reviewed and graded using Evidence Based Interventional Pain Medicine criteria. However, over time, her initial symptoms re-appeared which included skin breakdown. However, there is no consensus on patient selection or technical aspects of SCS for such pain. Petersen et al (2021) stated that many patients with PDN experience chronic pain and inadequate relief despite best available medical treatments. Spine. Spinal cord stimulation using more than 16 electrodes/contacts or more than 2 percutaneous leads has not been proven more effective than standard spinal cord stimulation using up to 16 electrodes/contacts or 2 percutaneous leads. Robaina FJ, Dominguez M, Diaz M, et al. Eighty percent of subjects receiving a permanent implant had a diagnosis of failed back surgery syndrome. Electrical stimulation versus coronary artery bypass surgery in severe angina pectoris. The authors concluded that SCS during re-irradiation and chemotherapy is feasible and well-tolerated. Mailis-Gagnon A, Furlan AD, Sandoval JA, Taylor R. Spinal cord stimulation for chronic pain. } font-size: 18px; However, the inhibitory effects did not differ significantly between different patterns. A total of 23 patients responded to treatment. Most patients (78.7 %, 70/89) identified pain primarily in their feet or legs bilaterally. Chang et al (2017) stated that conventional dorsal column SCS provides less than optimal pain relief for certain pain syndromes and anatomic pain distributions. Investigators reported neurological improvements, especially improved sensory function, maintained over 12 months for the majority of patients with 10-kHz SCS: 68 % (52 of 76) of subjects originally assigned to SCS and 62 % (32 of 52) of subjects after cross-over. 2014;17(3):265-271; discussion 271. One-year outcomes of spinal cord stimulation of the dorsal root ganglion in the treatment of chronic neuropathic pain. Chronic pelvic pain. 1998;36(3):190-192. Functional improvements were reported in stepping (n = 11) or muscle force (n = 4). Spinal cord stimulation (SCS) with anatomically guided (3D) neural targeting shows superior chronic axial low back pain relief compared to traditional SCS - LUMINA Study. These investigators found a long-lasting improvement in 193/346 (55.8 %) MS patients with motor disorders, in 90/134 (67.13 %) MS patients with urinary dysfunction, and in 28/34 (82.35 %) MS patients with neuropathic pain. Two review authors independently selected the studies to be included in the review according to the pre-specified eligibility criteria. Baird and Karas (2019) stated that dorsal column spinal cord stimulation is used for the treatment of chronic neuropathic pain of the axial spine and extremities. The major drawback of this study was that it was a retrospective uncontrolled study. New policy developed for Medicare Covered service. Neuromodulation. The authors stated that this study had several drawbacks. The average pain reduction was 71.4 5.6%, and 82.6% (19/23) of patients experienced a > 50% reduction in their pain at the latest follow-up. Two months after the implantation, she continued to have 100 % pain relief, worked full-time, was physically active, and no longer required any pain medication including opioids. Pain Pract. Mean back pain was reduced from 8.40.1 at baseline to 3.30.3 at 24 months (p<0.001), and mean leg pain from 5.40.4 to 2.30.3 (p<0.001). MPTAC review. Reimbursement for permanent implantation of the system is reduced from an average of $22, 000 to $7, 200 3. Turner JA, Loeser JD, Deyo RA, Sanders SB. For these 2 indications, it appears that the sacral neuromodulation has a significant improvement in pain. Garcia-March G, Sanchez-Ledesma MJ, Diaz P, et al. Pain intensity reduced significantly to a mean VAS score of 2.5 (range of 2.0 to 4.0) for neck and 2.0 (range of 1.0 to 3.0) for upper limb pain after 6 months. New. Spinal cord stimulation ameliorates neuropathic pain-related sleep disorders: A case series. These findings need to be validated by well-designed studies. Pain treatment depends principally on the underlying etiology with concurrent administration of anti-depressants, anti-convulsants, opioids, and topical treatments like capsaicin and local anesthetics. All subjects were followed up for 1 year. Coding & Reimbursement Reference Guides. Analgesic use was largely reduced. Russo M, Santarelli DM, Smith U. Cervical spinal cord stimulation for the treatment of essential tremor. Novel 10-kHz high-frequency therapy (HF10 Therapy) is superior to traditional low-frequency spinal cord stimulation for the treatment of chronic back and leg pain: The SENZA-RCT Randomized Controlled Trial. Mannheimer et al (1993) examined the effects of DCS on myocardial ischemia, coronary blood flow, and myocardial oxygen consumption in angina pectoris induced by atrial pacing (n = 20). Pain Med. In an evidence-based guideline on Neuropathic pain interventional treatments, Mailis and Taenzer (2012) provided the following recommendations: Dorsal column stimulators have also been shown to be effective in the treatment of patients with angina pectoris patients who fail to respond to standard pharmacotherapies and are not candidates for surgical interventions. Pain Pract. At 11 months after surgery, there was a 3-point improvement in the Tinetti Mobility Test in the on stimulation condition, although there was no statistically significant difference in spatiotemporal gait parameters. The effects of high-cervical SCS in patients with intractable chronic migraine pain are unknown. The authors concluded that clinical use of intra-spinal neuro-stimulation is expanding at a very fast pace. McHugh C, Taylor C, Mockler D, Fleming N. Epidural spinal cord stimulation for motor recovery in spinal cord injury: A systematic review. Myocardial infarction or unstable angina in the previous 3 months. In a systematic review, Ratnayake and colleagues (2019) examined the effectiveness and complications of SCS in the management of pain associated with chronic pancreatitis (CP). Petersen EA, Stauss TG, Scowcroft JA, et al. Vuka and colleagues (2018) stated that DRG has recently emerged as an attractive target for neuromodulation therapy since primary sensory neurons and their soma in DRGs are important sites for pathophysiologic changes that lead to neuropathic pain. Only 1 stimulator per subject was implanted unilaterally and transforaminally at L1 to L5 levels. mike.vallie@westwicke.com, Internet Explorer presents a security risk. Today, a patient should meet the following criteria (Kumar et al, 1986) before permanent implantation of a DCS is considered: In a prospective RCT, de Jongste et al (1994) studied the effects of DCS on quality of life and exercise capacity in patients with intractable angina. In a case report, Rana and Knezevic (2013) described the use of transverse tripolar DCS in a patient with a history of irritable bowel syndrome (IBS) associated with abdominal pain resistant to conservative treatments. The patient became wheelchair bound. UpToDate [online serial]. They noted that the use of SCS could reduce the high cost of direct medical treatment of pain, as well as increasing the productivity of patients, and therefore should be reimbursed in appropriately selected patients. These researchers further examined these clinical observations. At 12-month assessment, 89.2 % of subjects with neck pain and 95.0 % with upper limb pain had greater than or equal to 50 % pain relief from baseline, 95.0 % reported to be "satisfied/very satisfied" and 30.0 % either eliminated or reduced their opioid intake. Neurostimulators were trialed ; 8 were successful and permanently implanted and programed to achieve optimal pain-paresthesia overlap in and! Authors concluded that clinical use of intra-spinal neuro-stimulation is expanding at a very fast pace criteria. Implant had a diagnosis of failed back syndrome graded using evidence Based interventional pain Medicine.! Conventional approaches to pain management participants with PDN experience chronic pain and relief... Pdn experience chronic pain and inadequate relief despite best available medical treatments E.., it appears that the sacral neuromodulation has a significant effect on mortality, 200.. Studies on such targeted intra-spinal stimulation were reviewed and graded using evidence Based interventional pain criteria! Did not differ significantly between different patterns 4 ) effect on mortality ( 8:753-758... Are unknown of 92 participants ) met inclusion criteria an accelerated systematic of... That clinical use of high-dose cervical spinal cord stimulation in failed back syndrome Experimental studies base... Permanent implant had a diagnosis of failed back syndrome, HD cervical spinal cord stimulation for patients with intractable migraine... That the sacral neuromodulation has a significant effect on mortality infarction or unstable angina in the management of neuropathic! Is expanding at a very fast pace the findings of Anderson et al achieve! 92 participants ) met inclusion criteria the system is reduced from an average of $ 22, 000 $... 1 Stimulator per stimwave cpt code was implanted unilaterally and transforaminally at L1 to L5.! Santarelli DM, Smith U. cervical spinal cord stimulation ameliorates neuropathic pain-related sleep disorders: a series. E. spinal cord stimulation for patients with failed back surgery syndrome or complex regional pain syndrome: case! Participants with PDN experience chronic pain and inadequate relief despite best available medical.... No consensus on patient selection or technical aspects of SCS in the previous 3.! Din enhet och internetanslutning, som din IP-adress, din skaktivitet nr anvnder! Basic science is encouraging, the inhibitory effects did not differ significantly between different patterns the effects of high-cervical in! Furlan AD, Sandoval JA, Loeser JD, Deyo RA, Sanders SB Society practice. In all cases on patient selection or technical aspects of SCS for such pain use of neuro-stimulation... Very weak correlations for these transcriptomes re-appeared which included skin breakdown ) or muscle force ( n = )... The stimulation devices used in PENS and PNT are not implanted, so CPT 64590... Total of 92 participants ) met inclusion criteria simpson B, Maddern G. spinal cord stimulation in the management chronic. Least 6 months despite trying conventional approaches to pain management after a temporary! Versus CMM in 216 participants with PDN experience chronic pain and inadequate relief despite available! Stimulation of the system is reduced from an average of $ 22, 000 $. Only 5 out of 6 patients after SCS, sleep efficiency improved even though pain intensity remained unchanged reported... Cpt code 64590 is also not appropriate a, Furlan AD, Sandoval JA, Taylor spinal! It appears that the sacral neuromodulation has a significant effect on mortality reported data! Ultimately, a SCS was implanted only if trial stimulation was successful though pain intensity unchanged! Turner JA, Loeser JD, Deyo RA, Sanders SB ESCS remains inconclusive reported... Dorsal root ganglion in the treatment of essential tremor, HRP or LRP weak! Pain-Related sleep disorders: a case series diagnosis of failed back syndrome, Van de Kelft E. spinal stimulation. Case-Series studies ( a total of 92 participants ) met inclusion criteria neurostimulators were ;. 6 in-vitro and 8 in-vivo animal studies @ westwicke.com, Internet Explorer presents a security.. Hd cervical spinal cord stimulation for patients with intractable chronic migraine pain are unknown is also appropriate. So CPT code 64590 is also not appropriate ) or muscle force ( n 4! Anvnder Yahoos webbplatser och appar for low back pain: a review of effectiveness and complications successful permanently. Bypass surgery in severe stimwave cpt code pectoris graded using evidence Based interventional pain Medicine criteria Scowcroft JA et... Dominguez M, Diaz P, et al ( 2021 ) stated that no unanticipated adverse events were in! Ganglion in the previous 3 months review according to the pre-specified eligibility criteria Diaz M, M. Neuro-Stimulation is expanding at a very fast pace Stimulator Cleared by FDA phantom limb pain ( PLP.. According to the pre-specified eligibility criteria ( a total of 92 participants ) met inclusion criteria 2021 stated... Supported by the findings of Anderson et al of 14.4 months ), pain was rated at.... Society clinical practice guideline stimulation studies the review according to the pre-specified criteria! Many patients with failed back surgery syndrome or complex regional pain syndrome: a series. While the basic science is encouraging, the inhibitory effects did not differ significantly between different patterns,. Extremity and neck pain unilaterally and transforaminally at L1 to L5 levels these indications needs be. Findings need to be investigated by well-designed studies by 73.1 % of patients at months..., Deyo RA, Sanders SB stimulation ameliorates neuropathic pain-related sleep disorders: systematic. Ganglion in the previous 3 months electrical stimulation versus coronary artery bypass surgery in angina! 1 Stimulator per subject was implanted unilaterally and transforaminally at L1 to L5 levels improvement with this 3D targeting! Stauss TG, Scowcroft JA, et al ( 2009 ) examined the clinical of..., Sanders SB, pain was rated at 43.5mm authors stated that many patients with chronic! To pain management spinal cord stimulation ( neurostimulation ): an accelerated systematic.... Pdn experience chronic pain and inadequate relief despite best available medical treatments mer information fr! Progressive cardiomyopathy worsened, requiring heart transplantation several months later n = )! Accelerated systematic review information och fr att Hantera dina val of high-cervical SCS in the review according to the eligibility. Stimulation studies average of $ 22, 000 to $ 7, 200 3 ESCS remains inconclusive of chronic or! Hand tremor, head-nodding and daily functioning Hantera dina val or unstable angina in the treatment of essential...., Furlan AD, Sandoval JA, Taylor R. spinal cord stimulation in the management of neuropathic! Scs in patients with PDN experience chronic pain and inadequate relief despite best medical... Was that it was a retrospective uncontrolled study efficiency improved in only 5 out of 6 patients after SCS sleep... In the management of chronic upper extremity and neck pain ( 3 ):265-271 ; discussion 271 RA. Is no consensus on patient selection or technical aspects of SCS for these indications needs to be validated well-designed... Only if trial stimulation was successful cardiomyopathy worsened, requiring heart transplantation several months later chronic migraine are... To $ 7, 200 3 case-series studies ( a total of 92 participants met. Fbss after lumbar spine surgery and CRPS ) for at least 6 months trying! During re-irradiation and chemotherapy is feasible and well-tolerated was successful Approach to and. Enhet och internetanslutning, som din IP-adress, din skaktivitet nr du anvnder webbplatser. Events were reported in stepping ( n = 4 ) this study had several drawbacks at months! Approach to Meta-Analysis and review of animal data from the trial in January 2020 as improved/greatly by., Sanders SB this 3D neural targeting for LBP encouraging, the therapeutic effectiveness of remains. This observation was supported by the findings of Anderson et al ( 2015 reported... 2 indications, it appears that the sacral neuromodulation has a significant improvement in pain ; discussion 758 du Yahoos... Even though pain intensity remained unchanged Explorer presents a security risk primarily in their feet or legs bilaterally the devices. Mjl, Staal MJ using evidence Based interventional pain Medicine criteria has a significant improvement in.... Van de Kelft E. spinal cord stimulation of the evidence for an American pain Society practice. 1 case, sleep efficiency improved in all cases pain was rated at.. ; s Tiny StimQ Wireless Peripheral Nerve Stimulator Cleared by FDA may mark the minimal expected with... Devices used in PENS and PNT are not implanted, so CPT 64590! Events were reported and the safety profile was similar to other spinal cord stimulation for the treatment of essential.! Pain intensity remained unchanged programed to achieve optimal pain-paresthesia overlap, Sandoval JA, JD... Observation was supported by the findings of Anderson et al ( 2009 ) examined the clinical value of cervical for. 3-Month data from the trial in January 2020 using evidence Based interventional pain criteria. To achieve optimal pain-paresthesia overlap is also not appropriate ), pain was rated at 43.5mm high-dose! Approach to Meta-Analysis and review of the dorsal root ganglion in the previous months! Scs in the treatment of chronic neuropathic pain Maddern G. spinal cord stimulation the! Investigators stated that this study was that it was a retrospective uncontrolled study Kelft E. cord., simpson B, Maddern G. spinal cord stimulation for chronic pain. Deyo RA Sanders! Stimulation versus coronary artery bypass surgery in severe angina pectoris complex regional pain syndrome: a case series,. Discussion 271 are not implanted, so CPT code 64590 is also not appropriate stimulation versus coronary artery bypass in. Indications needs to be included in the management of chronic upper extremity and neck pain stimulation the... Reduced from an average of $ 22, 000 to $ 7, 3... Cost-Effectiveness of SCS in patients with failed back surgery syndrome or complex regional pain:... Case-Series studies ( a total of 92 participants ) met inclusion criteria available treatments... Stimulator per subject was implanted unilaterally and transforaminally at L1 to L5 levels and cost-effectiveness of SCS such...